Abstract

Abstracts from the ISSAID 2021 Periodic Congress

Highlights

  • Systemic Auto Inflammatory Diseases(SAID) is a group of rare hereditary fever syndromes

  • In summary, these results provide a mechanistic explanation for the strong inflammatory manifestations associated to COVID-19 and further evidence that NLRP3 and IL-1β targeting could represent an effective strategy in this disease

  • Even if lactate dehydrogenase (LDH) is not included in 2016 classification criteria for Macrophage Activation Syndrome (MAS) in sJIA, we have found that this parameter could help to discriminate MAS in sJIA, in addition to the others

Read more

Summary

Introduction

Systemic Auto Inflammatory Diseases(SAID) is a group of rare hereditary fever syndromes. Systemic autoinflammatory diseases (SAIDs) delineate a group of clinical entities caused by an anomaly of the innate immune response that includes rare periodic fever syndromes characterized by uncontrolled production of the proinflammatory cytokine interleukin-1 (IL-1) Patients suffering from these conditions experience severe and recurrent inflammation ranging from fevers to gradual hearing loss, blindness, and organ failure due to amyloid accumulation. At 13-years-old, new DNA samples were obtained from the patient and his parents and the genetic autoinflammatory disease study was widen by capturing and sequencing the flanking exonic and intronic areas of the following 17 genes: MEFV, MVK, TNFRSF1A, NOD2, NLRP3, NLRC4, NLRP12, IL1RN, IL6RN, PLCG2, PSTPIP1, CARD14, TMEM173, PSSMB8, LPIN2, CECR1 and TNFAIP3. Medical professionals should pay more attention to these information before administering the vaccine

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.